Schedule 13D ownership disclosure
Arsanis, Inc.
Security class unavailable · CUSIP: 042873109
Event date: 2017-11-20
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 13.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-17-355669
- Form type
- SC 13D
- Filer
- X4 Pharmaceuticals, Inc
- CIK
- CIK 1501697
- Filed
- Nov 29, 2017
- Reporting period
- Nov 20, 2017
- Description
- Schedule 13D beneficial ownership